Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$0.57 - $0.99 $30,685 - $53,296
53,835 Added 3.31%
1,681,235 $1.4 Million
Q1 2023

May 12, 2023

BUY
$0.51 - $0.78 $50,286 - $76,908
98,600 Added 6.45%
1,627,400 $970,000
Q4 2022

Feb 13, 2023

SELL
$0.47 - $17.22 $253,753 - $9.3 Million
-539,900 Reduced 26.1%
1,528,800 $841,000
Q3 2022

Nov 14, 2022

SELL
$0.74 - $15.01 $239,267 - $4.85 Million
-323,335 Reduced 13.52%
2,068,700 $1.45 Million
Q2 2022

Aug 12, 2022

BUY
$0.71 - $2.43 $762,422 - $2.61 Million
1,073,835 Added 81.46%
2,392,035 $2.36 Million
Q1 2022

May 13, 2022

BUY
$2.31 - $5.13 $2.04 Million - $4.52 Million
881,200 Added 201.65%
1,318,200 $3.14 Million
Q4 2021

Feb 11, 2022

BUY
$4.45 - $8.09 $1.94 Million - $3.54 Million
437,000 New
437,000 $2.08 Million
Q2 2021

Aug 13, 2021

SELL
$7.45 - $16.27 $4.55 Million - $9.94 Million
-611,004 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$8.78 - $12.8 $8.67 Million - $12.6 Million
-987,220 Reduced 61.77%
611,004 $6.92 Million
Q4 2020

Feb 10, 2021

BUY
$1.08 - $8.2 $58,125 - $441,323
53,820 Added 3.48%
1,598,224 $13.1 Million
Q3 2020

Nov 13, 2020

SELL
$0.95 - $1.42 $626,520 - $936,482
-659,495 Reduced 29.92%
1,544,404 $1.81 Million
Q2 2020

Aug 13, 2020

BUY
$0.63 - $1.7 $372,578 - $1.01 Million
591,395 Added 36.68%
2,203,899 $2.67 Million
Q1 2020

May 14, 2020

BUY
$0.67 - $1.85 $49,647 - $137,085
74,100 Added 4.82%
1,612,504 $1.14 Million
Q4 2019

Feb 13, 2020

BUY
$1.36 - $2.44 $224,235 - $402,304
164,879 Added 12.0%
1,538,404 $2.62 Million
Q3 2019

Nov 13, 2019

BUY
$1.74 - $2.83 $316,864 - $515,359
182,106 Added 15.28%
1,373,525 $3.08 Million
Q2 2019

Aug 12, 2019

BUY
$1.36 - $2.35 $276,882 - $478,436
203,590 Added 20.61%
1,191,419 $2.22 Million
Q1 2019

May 14, 2019

BUY
$0.78 - $2.01 $128,544 - $331,247
164,800 Added 20.02%
987,829 $1.97 Million
Q4 2018

Feb 13, 2019

BUY
$0.62 - $2.25 $510,277 - $1.85 Million
823,029 New
823,029 $568,000

About CURIS INC


  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $409M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.